Emergency Medicine Clinics of North America 2002: Vol 20 Index

19 Pages·2002·3 MB·English

EMERGENCY
MEDICINE
CLINICS OF
Emerg Med Clin N Am NORTH AMERICA
20 (2002) 995-1013
Subject Index to Volume 20
Volume 20
February PEDIATRIC EMERGENCY MEDICINE: CURRENT CONCEPTS AND
CONTROVERSIES, pages 1~253
May BIOTERRORISM, pages 255-535
August STROKE, pages 537-737
November ADVANCES IN PREHOSPITAL CARE, pages 739-1013
Note: Page numbers of article titles are in boldface type
A Airway, management of, advances in,
Abdominal emergencies, in children, 845-859
139-153 in intracerebral hemorrhage,
general approach in, 139-140 641-643
in pediatric resuscitation, 10-12
Acetaminophen, 204-205 protection of, in stroke, 690
elimination of, 242 unprotected, adverse consequences of
overdose of, in child, 241—244 ventilation with, 846-848
N-Acetylcysteine, in acetaminophen Albuterol, in acute asthma, 124-125
overdose, 243
Alphaviruses, 982
Acne, neonatal, 29 clinical presentation of, 317-318
Activated charcoal, in pediatric poisonings, diagnostic testing in, 318
939 933 treatment of, 318
Advanced cardiac life support (ACLS), and American Heart Association, pediatric
chain of survival, efficacy issues for, resuscitation guidelines of, 6-7
762-766 Amicar, in von Willebrand disease, 193-194
assessment of outcomes in, 760-761
cost considerations and, 761-762 Aminophylline, in acute asthma, 131
defibrillation in, 761-762, 763-764 Amiodarone, for pediatric resuscitation,
early CPR in, 762-763 15-16
endotracheal intubation and, 764
pharmacologic interventions in, Amphetamines, and stroke, 660
764-766
Amrinone, in calcium channel blocker
prehospital, 759-770
overdose, 241
Advanced life support, chain of survival in,
Anaigesia, definition of, 201
7-8
sedation and, pediatric, contemporary
guidelines for, current, 7-8 trends in, 199-222
development of, 6-7
state of, 1-5 Analgesics, nonopioid, 204-205
Advanced Trauma Life Support, for Anemia, autoimmune hemolytic, 184
diagnosis of multiple trauma victims, differential diagnosis of, 179
353 iron deficiency in, 178-190
secondary survey, expansion of, pathology of, 179
356-362 pediatric hemogram in, 177-178
traditional survey, expansion of, 356 sickle cell. See Sickle cell anemia.
0733-8627/02/S - see front matter © 2002, Elsevier Science (USA). All rights reserved.
Pil: S0733-8627(02)00062-7
996 Subject Index | Emerg Med Clin N Am 20 (2002) 995-1013
Anesthetics, local, 207-209 incidence of, 140
topical, 208 management of, 142
Anthrax, 978-980 Arena viruses, 376-377
bioterrorism-related inhalational, 280,
281 Arterial dissection, stroke in, 659-660
clinical presentation of, 278 Arteritis, as cause of stroke, 659
cutaneous, 278-279
diagnosis of, 280-282 Aspirin, 204
endemic inhalational, 279-280 in stroke, 619-620, 680, 686
gastrointestinal, 279 in transient ischemic attack, 602
history and significance of, 274-278 Asthma, acute exacerbations of, clinical
in children, diagnosis and treatment scores in, 120
of, 379-380 definition of, 116
in pregnancy, treatment of, 372 disposition from emergency
infection control precautions and, department following.
282-283 133-134
terrorism involving, 332 history taking in, 117
treatment and prophylaxis of, 283-284 management of, goals of, 117,
118-119
Anthrax Vaccine Adsorbed, 283-284
outpatient treatment following,
Antibioiic therapy, for children, in bacterial 134
agents of bioterrorism, 386 physical examination in,
in bacterial agents of terrorism in 117-120, 122-123
pregnancy, 371—372, 373-374 pulmonary function tests in,
120-121
Antibiotics, appropriate use of, for common
pulse oximetry in, 124
infections, increasing resistance and,
69-91 treatment of, 124-132
in children, 72 triggers for, 116
parental pressure pediatric, emergency department
management of, 115-138
and, 72-73
problem statement on, 115-116
in bronchiolitis, 99
overprescribing of, 72 Aum Shinrikyo, contamination of Tokyo
prophylactic, to reduced infection, 187 subway system by, 262
resistance to, history of, 70-73
resistance to bacterial pathogens,
62-63
Anticholinergic agents, in acute asthma,
128-129 Bacillus anthracis. See Anthrax.
Anticoagulation, in stroke, 620-621, 680. Bacteremia, occult, in febrile children,
688 56-63
antibiotics in, 61-62
Antimicrobials, bioterrorism defense
parental values and, 60-61
research and, 518-519
pneumococcal vaccine in, 63
biowarfare agents and, 512
rapid identification of, new techniques
history of, 70
for. 59-60
in pregnancy, risk categories of, 369
Bacteria, infectious, as biologic weapons,
Antiphospholipid antibody syndrome, as
978-981
cause of stroke, 658-659
Bag-valve-mask ventilation, 845-846
Antiterrorism, federal programs and, alternatives to, 850-855
482-485
tidal volume for, 848-850
Apnea, in newborn, 38-39
Barbiturates, 212-213
Appendicitis, clinical presentation of,
Benzodiazepines, 213
140-141
diagnostic studies in, 141-142 Beta-2-agonists, systemic, in acute asthma,
differential diagnosis of, 142 131
Subject Index | Emerg Med Clin N Am 20 (2002) 995-1013 997
Beta-agonists, inhaled, in acute asthma, Biological Weapons Convention (1972), and
124-128, 130, 134-135 biologic warfare agents, 260
Biologic agent(s). critical, Centers for Biotechnology, potential impact on
Disease Control and Prevention 1997 terrorism, 503-504
study and, 265
Bioterrorism, animal-related, veterinary
identification of, in biologic
diagnostic laboratory support for.
agent-caused syndromes, 331
345-346
of terrorism, 264
cause of crisis related to, 394
Biologic agent-caused syndromes, 360 children and, 377-383
biologic agent identification in, 331 antibiotic therapy for bacterial
diagnostic analyses of, 331-350 agents of, 386
emergency physicians and clinical special vulnerabilities to, 378-379
laboratory communication in, emotional consequences of,
331-332 anticipation of event and. 394
exposure to, without warning, 397 federal response to, 485
pathologic consequences in, 397 future challenges in, 501-524
pediatric considerations in, 379-383 future defense research in, 516-520
range of manifestations of, 360 infection control measures following.
recognition and initial management of, 405
352 laboratory diagnostics and
identification issues associated
Biologic attack, identification of, 504-510
with, 509
medical and health communities and,
media response to, planning for,
256
402-403
public health response to, Centers for
medical management of, problems
Disease Control and Prevention related to, 401-403
and, 351—352, 354-355
mental health effects of, 394
risk of, 256
primary and secondary emer-
Biologic warfare, and terrorism, global gency prevention and,
trends and effects on global politics, 394-396
262 mental health response to, planning
history and threat of, 255-271 for, 403-405
National Intelligence Council neuropsychiatric syndromes in,
and, 262 398-399, 400
technologic edge of United States prevention of, 504
and, 262-263 psychosocial casualties of, 393
threat of, 262-263 public information plans for, 402
offensive, traditional agents of, 263 state and federal response to, 477-499
surveillance system issues and,
Biologic warfare agents, 256
505-507
Biological Weapons Convention suspected incident of, environmental
(1972) and, 260
sampling in, 345
during World War II, 258-259 sample collection in, 346-347
early examples of, 256-257 suspected victim of, medical
pre-World War II era, 257-258
management of, 351-364
Biologic weapons, and chemical weapons of therapeutic interventions in, 399-401
mass destruction, 977-995 threats in, CDC category A gents in,
decontaminataion and personal 273-309
protective equipment against, CDC category B and C gents in.
983-984, 985 311-329
detection of, 983 traumatic stress response to, 396-397
Gulf War and, 261—262 vulnerable populations in setting of.
history of, 977-978 365-392
Soviets and, 260-261
Bioterrorism agent(s), bacterial, in
types of, 978-983 pregnancy, antibiotic therapy in,
Biologic weapons programs, offensive, 371-372, 373-374
nations having, 265-266 exposure to, in elderly immuno-
compromised patients, 383
998 Subject Index | Emerg Med Clin N Am 20 (2002) 995-1013
Bioterrorism agent(s) (continued ) nature of problem, 437-438
identification of, laboratory potential, features alerting
component of, 333-336 epidemiologists to, 460
rapid, importance of, 348-349 pre-clinical diagnostics and, 509-510
technical components of, prophylaxis, post-exposure measures,
346-348 and treatments in, 510-512
immune response to, in cancer protection of community personnel
treatment, 385 and response organizations in,
in organ transplantation, 385 463-465
medical sample collection of, 340-343 public notification of, 468
potential, clinical and laboratory rehabilitative services following,
characteristics of, 337-339 469-470
response operations in, management
Bioterrorism event(s), biologic attack in,
of, 468-469
risk to emergency physicians in, 404
surveillance and event discovery of,
risk to primary care physicians 458
in, 404
syndromic surveillance and, 459
community activation for, 462
community preparation for, 457-476 Bleeding, child presenting with, 191-196
community recovery following, 469 gastrointestinal, in newborn, 35
community response to, 462
containment in, 463 Blood pressure elevation. preoperative,
hemorrhage and, 958-959
data mining and, 460-462
education of healthcare professionals Bone marrow transplantation, and stroke,
and, 512-516 661
emergency department and hospital
preparedness for, 437-455 Botulinum toxins, 982-983
emergency management of mental Botulism, clinical presentation of, 302-303
health in, 393-407 diagnosis of, 304
emergency response to, 462-463 during pregnancy, clinical features of,
environmental detection of, 507-509 374-375
environmental surveillance and, treatment of, 375
458-459 history and significance of, 301-302
epidemiologic surveillance and, 459 in children, clinical manifestations of,
federal response to, 487-494 381
health consequences of, management treatment of, 381-383
of, 465-468 infection control precautions in, 304
healthcare system preparedness issues treatment and prophylaxis of, 304-305
and, 512-516
healthcare system response planning Brain, computed tomography of, analysis
for, 470-471 of, 555-564, 568-576
large-scale, mass casualty management assessment of symmetry in,
of, 409-436 573-575
legislative activity following, 516 location of hemorrhage in,
management plan for, 442-453 564-571, 570-573
activation and notification in, to examine parenchymal changes,
442 443 574, 575
alternative care sites in, 446-448
Breast engorgement, in newborn, 29
command and control in, 451
coordination and communication Breathing, in pediatric resuscitation, 10-12
in, 451-453
Bronchiolitis, 93-103
decontamination in, 445-446
clinical presentation of, 95-96
expansion of services in, 446-448
diagnosis of, 96-97
facility protection in, 443-445
epidemiology and etiology of, 94-95
recovery issues in, 453 outcome of, 102
staff education and training in,
prevention of, 101-102
449-451
respiratory distress in, 95-96
supplies and logistics in, 448-449
treatment of, 97-101
mass fatality management following,
468 Bronchodilators, in bronchiolitis, 97-98
Subject Index | Emerg Med Clin N Am 20 (2002) 995-1013
Brucellosis, 980 Carotid ultrasonography, in transient
clinical presentation of, 314-315 ischemic attack, 600
diagnostic testing in, 315
Catheter sites, infected, management of,
infection control precautions in, 315
187-188
treatment and prophylaxis of, 315-316
Centers for Disease Control and Prevention,
Budesonide, in croup, 109
1997 study of, 269
Bupivacaine, 208 and public health response to biologic
attack, 351-352, 354-355
Bystander resuscitation, in
category A agents, 273-309
cardiopulmonary arrest, 8-9
category B agents, 311, 313-323
category C agents, 311~312, 323-328
critical biologic agents and, 265
c list of “Critical Biological Agents” of,
273-274
Calcium channel antagonists, as toxin in
Cerebellar infarcts, computed tomography
child, 238-241
to assess, 579
types of, 239
Cerebral amyloid angiopathy, intracerebral
Cancer, treatment of, immune response to
hemorrhage in, 633-634
agents of bioterrorism in, 385
smallpox vaccination during, Cerebral edema, increased, after stroke,
385-386 treatment of, 692-693
Cardiac arrest, sudden, prehospital, Cerebral infarcts, computed tomography to
outcomes after, 761 assess, 579
versus circulatory arrest, defining of,
964 Chemical asphyxiants, as chemical warfare
agents, 991-992
Cardiac support, advanced. See Advanced
Chemical warfare agents, and biologic
cardiac life support (ACLS).
weapons of mass destruction, 977-995
Cardiopulmonary arrest, bystander characteristics of, 987
resuscitation in, 8-9 history of, 984
pediatric, incidence and etiology types of, 985-994
of, 2-3
Chest radiography, in acute asthma,
survival following, 3-4
132-133
factors associated with, 4-5
postarrest stabilization following, Child(ren), abdominal emergencies in,
16-17 139-153
anthrax in, diagnosis and treatment of,
Cardiopulmonary resuscitation, active
379-380
compression-decompression, 776-778
appropriate use of antibiotics in, 72-73
and interposed abdominal
bioterrorism and, 377-383
counterpulsation, 775-776
blood flow during, mechanisms of, antibiotic therapy for bacterial
772-174 agents of, 386
special vulnerabilities to, 378-379
early, in advanced cardiac life support,
762-763 botulism in, clinical manifestations of,
381
impedance threshold valve and,
treatment of, 381-383
779-781
considerations in, in biologic agent-
mechanical devices for, 771-784
caused syndromes, 379-383
mechanical piston devices for, 778
death of, coping following
methods of, in pediatric resuscitation,
resuscitation efforts, 17-18
12
deceased, caring for family of, 18-20
phased thoracoabdominal
infants and, fever in, management of,
compression-decompression in,
49-67
781-782
plague in, diagnosis and treatment of,
with circumferential vest, 774-775
380-381
Cardiovascular care, emergency, automated respiratory infections in, new
external defibrillators and, 816-817 approaches to, 93-114
1000 Subject Index | Emerg Med Clin N Am 20 (2002) 995-1013
Child(ren), abdominal (continued ) to examine parenchymal changes,
smallpox in, manifestations of, 381 574, 575
stroke in, 669-683 of head, interpretation of, 566-576
younger than 6 years, causes of death scanning in, 554, 567
in, 224 of skull, in trauma, 576
to assess ischemic patterns of stroke,
Child abuse, emergancy management in, 45 575, 576-579
Chloracetophenon, 993-994 to assess lacunar, cerebral, and
cerebellar infarcts, 579, 580
Chloral hydrate, 212 to study stroke, indications for,
Chlorine, 992 557-559
Cidofovir, in smallpox, 288 Comstipation, in newborn, 33-34
Ciprofloxacin, in anthrax, 284 Congestive heart failure, in newborn, 40
in botulism in children, 382 Conjunctivitis, in newborn, 30
Circulation, management of, in pediatric Consciousness, altered level of, in newborn,
resuscitation, 12-14
41 44
Circulatory arrest, trauma-associated, 964 Corticosteroids, in croup, 107-109
versus cardiac arrest, defining of, 964 systemic, in acute asthma, 128, 135
Circumcision, complications of, 31 Coumadin therapy, intracerebral
Clonidine, as toxin in child, 235-237 hemorrhage associated with, 635
Clopidogrel, in transient ischemic attack, Coxiella burnetti. See Q fever.
603
“Cradle cap,” 29
Clostridium botulinum. See Botulism. Croup, clinical presentation of, 103-104
CN, 993-994 diagnosis of, 104
differential diagnosis of, 104-105
Coagulopathies, as cause of stroke, 657-658 etiology and epidemiology of, 103
stroke in children in, 673-674, 679 treatment of, 105-109
Cocaine, stroke induced by, 660 Crying, by newborn, 45-46
Codeine, 206 Cryptosporidium parvum, in bioterrorism,
Colic, by newborn, 45, 46 322
Combitube”, 850 CS, 993-994
in management of difficult airway, Culture, in microbiology laboratory, 347
854-855
placement of, 851 Cyanide, 991-992
Community, preparation of, for Cytokines, bioterrorism defense research
bioterrorism events, 457-476, 515-516 and, 517-518
Computed tomography, advanced, in acute
stroke care, 716-717
background of, 566, 567-568
D
emergent, for evaluation of stroke,
553-584 Dark Winter exercises (2001), 268
for evaluation of intracerebral Death, causes of, in children younger than 6
hemorrhage, 639-641 years, 224
in headache evaluation, 562-565
of brain, analysis of, 555-564, 568-576 Decontamination, following bioterrorism
assessment of symmetry in, event, 465, 511-512
573-575
Deep venous thrombosis, in stroke,
emergent scan, in acute ischemic
prevention of, 690-691
stroke, 614-615
location of hemorrhage in, Defibrillation, biphasic shocks, superior
564-571, 570-573 efficacy of, 796-797
Subject Index | Emerg Med Clin N Am 20 (2002) 995-1013
early, principle of, 810-811 E
external, biphasic waveform for, Ebola, 300, 376
797-798
hypotheses and electrophysiologic Educating Health Care Professional(s),
mechanisms of, 789-791 continual reassessment and
in advanced cardiac life support. intervention by, 358
761-762, 763-764 decontamination by, 359
public access, 809-825 diagnosis, treament, and epidemic
coordination with emergency control by, 359
medical support systems, expansion of secondary survey by.
820 356-362
deployment strategies, 819 expansion of traditional primary
incidence and location of cardiac survey by, 356
arrest and, 819-820 issuance of appropriate warnings by,
Phase | trial, 820-821 362
trials and outcomes of, 817-819 prevention of spread of disease by,
use by rescuers, 819 362
rectilinear biphasic waveform for, prompt recognition of bioterrorism
798-799 agents by, 357-359
transthoracic, historical development protection of, in investigation of
of, 786-787 agents of bioterrorism, 358-359
new concepts in, 785-807 provision of therapy by, 361
virtual electrode polarization and,
Electrocardiogram, prehospital 12-lead,
791-796
diagnostic programs, 827-843
Defibrillator, automated external, in equipment for, and cost
pediatric resuscitation, 13-14 effectiveness of, 829-830
feasibility of implementing, 829
Defibrillators, automated external. implementing effective program
definition of, 811 for, 838, $39, 840
emergency cardiovascular care improved interpretation of, 833
and, 816-817 potential benefits of, 830-833
function and usability of, 812 present and future applications
future issues for, 815 of, 833-836, 837
in-hospital use of, 817
in public access defibrillation, Electrochemiluminescence assays, 348
809-810
Emergency department, and hospital,
out-of-hospital BLS providers
preparedness of, for bioterrorism
and, 816-817
events, 437-455
waveforms of, 812-815
Emergency Management Assistance
Delirium, as consequence of bioterrorism,
Compact, 486
treatment of, 399-400
Emergency Management Strategic
Department of Health and Human Services,
Healthcare Group, 484
479, 482, 483, 490
Emergency medical dispatch (EMD),
Dexamethasone, in croup, 107, 108, 109
861-877
Diaper rash, candidal, 30 background of, 862-863
Criteria-Based Dispatch system and,
Diarrhea, in newborn, 34-35
864-865
Diphosgene, 992-993 dispatch systems and, 864
dispatch training for, 863
Dipyridamole, extended-release, and future of, 871-872
aspirin, in transient ischemic attack, information provided to dispatcher,
603-604 869
Disseminated intravascular coagulation, medical control in, 867
thrombocytopenia in, 190-191 medical/legal risk and, 872-873
medical priority dispatch system and,
DPT, 211-212 865-866
Subject Index | Emerg Med Clin N Am 20 (2002) 995-1013
Emergency medical (continued) medical assessment by, 948
prearrival instructions for, 866-867 medical direction of, 746
predictive strength of local dispatch operational issues in, 915-929
protocols and, 870-871 paramedic and emergency medical
referral systems and, 872 technician, targeting resources
role of emergency medical dispatcher of, 924
in, 863 paramedic experience in, strategies for
telephone-assisted cardiopulmonary increasing, 921
resuscitation and, 868 paramedic supervisors in, 924
training goals, 863-864 patient preferences, EMTALA and,
warning lights and siren for, 867-868 909
performance of, ethical breaches in,
Emergency medical services (EMS),
901-902
abandonment by, 906-908
principle-based ethical challenges
acute stroke evaluation by, 881-883
in, 901
advance directives and, 909
physician mentors for, 926-927
Agenda for the Future, 739, 740,
752-754 priority medical dispatch of,
922-923
alerting of stroke team by, 548-550
privacy threats to, 908-909
algorithms of, and prehospital care in
public access to, 748-749
major trauma, 955-956
public education about, 747-748
American experience with, 917
research by, 740
and initial stabilization, in stroke,
546-548 and waiver of consent, 908
respect for patient autonomy, 905
and patient care issues, in stroke,
rural systems, 925-926
543-546
safe driving in, 904
background of, 739-740
scene safety and, 947
beneficence in, performance threats to,
scene termination and, 910
902-905
scope of practice of, 904-905
clinical care and, 750
system finance, 744-745
communications systems, 749-750
system of, components of, 918-920
design for stroke management,
883-884 design issues and, 917-926
target response versus uniform
dispatch of, 541-542
response by, 920-921
education and training for, in stroke,
542-543 teamwork in, barriers to, 891-892
ethics of, 890-891
education systems, 746-747
theoretic concerns/premises of,
endotracheal intubation by, 902-904 893-894
equipment of, 947 triage and resource allocation by, 910
essential ethics for, 889-913
versus tactical emergancy medical
European influence on, 916-917
support (TEMS), 946-949
evaluation of, 751-752
virtue-based ethics in, 892-893
first responders of, 923-924
virtues in: communication, 899
four areas of, in stroke, 543
virtues in: compassion, 897-898
future of, agenda for, 739-757
virtues in: confirmation, 900-901
vision for, 740-742
virtues in: empathy, 899
future role in stroke management, 886
Virtues in: justice, 895-896
historical perspective on, 916-917
virtues in: nonjudgment, 896
history taking by, in stroke, 543-544
virtues in: prudence, 895
hospital phase of, trauma centers and,
924-925 virtues in: resilence, 898-899
virtues in: self-disclosure, 900
human resources and, 745
virtues in: self-effacement/charity,
impairment and, 905 896-897
in prehospital care of stroke patient,
537-538, 541 virtues in: shared power and control,
899
information systems, 750-751
virtues in: trustworthiness, 898
informed consent/informed refusal for,
908 Emergency medical support, tactical. See
injury and illness prevention and, 748 Tactical emergency medical support
legislation and regulation of, 743-744 (TEMS).
Subject Index | Emerg Med Clin N Am 20 (2002) 995-1013 1003
Emergency physicians, and clinical Federal Emergency Management Agency,
laboratory communication, in biologic 479, 482, 483, 488-489
agent-caused syndromes, 331-332
Fentanyl, 206
in diagnosis of stroke, 554-557
risk to, following biologic attack, 404 Fetal smallpox, 367
Emergency practitioners, future role of, in Fetal vaccinia, 370
acute stroke care, 723-725
Fever, in children, in occult bacteremia.
EMLA, 208 See Bacteremia, occult, in febrile
children.
Encephalitides, viral, 982
in occult urinary tract infection,
Encephalitis, tick-borne, 325 55-56
West Nile virus, 332 in infants, and in children,
management of, 49-67
Encephalomyelitis, eastern and western
bacterial disease in, 50
equine, 317-318
chest radiographs in, 53-54
Venezuelan, 317-318
low-risk, screening for, 51-53
Encephalopathies, mimicking stroke, 592 older, and in toddlers, 54—55
preliminary reseaarsh in, 51
Endotracheal intubation, advanced cardiac younger than | month of age, 54
life support and, 764 in newborn, 35-37
by emergency medical services,
902-904 Fever phobia, 63-64
during pediatric resuscitation, 10-11
Filoviruses, 376
Epidemic curves, 413
Fluid resuscitation, in uncontrolled
Epinephrine, high-dose, for pediatric hemorrhage, 961-962
resuscitation, 14-15 preoperative, complications of,
racemic, in croup, 105-107 962-964
Epsilon poisoning, from Clostridium Flumazenil, 215
perfringens, 320
Fluori-methane, 208-209
Erythrocytopenia, transient, of childhood,
Fogging effect, 579
184-185
Food-borne pathogens, 321-323
Escherichia coli, in bioterrorism, 321-323
Francisella tularensis. See Tularemia.
Esophageal detector device, in tracheal tube
placement, 11
Ethics, issues of, and informed consent, in G
treatment of acute stroke, 701-713
Gastroesophageal reflux disease, 144
Ethyl chloride, 208-209
Gastrointestinal bleeding, in newborn, 35
Etomidate, 211
Gastrointestinal complaints, in newborn,
Exercises, weapons of mass destruction 31-35
readiness, 267-268
Gene amplification assays, 347
Extracorporeal membrane oxygenation, in
bronchiolitis, 101 Glanders, clinical presentation of, 316
diagnostic testing in, 316-317
Eyes, exposure to toxins, management of, infection control precautions in, 317
233 treatment and prophylaxis of, 317
Glucagon, in calcium channel blocker
overdose, 240
F
Glucocorticoids, in bronchiolitis, 98-99
Factor IX deficiency, 196
Glucose-6-phosphate dehydrogenase
Factor VIII deficiency. See Hemophilia A. deficiency, 183
Federal Bureau of Investigation, 488, 489 Gulf War, and biologic agents, 261-262
1004 Subject Index | Emerg Med Clin N Am 20 (2002) 995-1013
H Hemophilia A, bleeding in, 195
Haemophilus influenzae, type B, bacteremia incidence of, 194
associated with, 58-59 inhibitors in, 195-196
treatment of, 194
Hantaviruses, 324-325
Hemophilia B, 196
Head, computed tomography of,
interpretation of, 566-576 Hemorrhage, cerebral, location of,
scanning in, 554, 567 computed tomography for, 564-571,
570-573
Head and neck, and skin, of newborn, following blunt versus penetrating
complaints concerning, 28-30 trauma, management of, 959-961
intracerebral, 631-654
Head injury, blunt, prehospital care in,
967-969 airway management in, 641-643
anticoagulation reversal in,
closed, in children, disposition in,
646-647
164-165
blood pressure management in,
epidemiology of, 162
643-644
evaluation of, 163-164
presentation of, 162-163 clinical presentation of, 637-639
computed tomography for
Headaches, evaluation of, computed evaluation of, 639-641
tomography in, 562-565 definition of, 631
in children, classification of, 165-166 epidemiology of, 631-632
epidemiology of, 165 fluid management in, 645-646
evaluation of, 167-168 increased, management of,
presentation of, 168 644-645
therapy of, 168 management of, 641-647
pathophysiology of, 636-637
Health community, biologic attack and,
256 prevention of, 648
prognosis in, 637
communication in, in preparation for
bioterrorist attack, 516 risk factors for, 632-636
seizure prevention in, 646
Health services, integration of, 742 surgical intervention in, 637-648
post-traumatic, prehospital care in,
Healthcare services, capacity of, methods to 956-964
increase, 467
preoperative blood pressure elevation
system preparedness issues of, and, 958-959
bioterrorism attack and, 512-516
uncontrolled, fluid resuscitation in,
Healthcare system, 741 961-962
Heart disease, congenital, 39-41 Hemorrhagic conversion, after stroke,
categories of, 39 treatment of, 693, 694
differential diagnosis of, 39-40
Hemorrhagic fevers, viral, 982
management of, 41
clinical presentation of, 298-300
radiographic findings in, 40-41
diagnosis of, 300
stroke in children in, 676
history and significance of, 298,
Heliox, in acute asthma, 132 299
in bronchiolitis, 100 infection control precautions in,
300
Hematologic emergencies, in pediatric treatment and prophylaxis of,
emergency room, 177-198 301
Hemiparesis, functional, as stroke mimic, Hirschsprung disease, 34
592
HIV, and stroke, 660-661
Hemodialysis, to eliminate toxins, 234-235
Homocystinuria, stroke in children with,
Hemogram, pediatric, in anemia, 177-178 679
Hemolytic anemia, autoimmune, 184 Hospital(s), diaster planning in, assessment
Hemolytic uremic syndrome, and of risks, capabilities, and capacity in,
thrombocytopenia, 190 440 442